Compare VISTA PHARMA with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VISTA PHARMA vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VISTA PHARMA IPCA LABS VISTA PHARMA/
IPCA LABS
 
P/E (TTM) x -68.1 27.8 - View Chart
P/BV x 1.2 6.0 20.9% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 VISTA PHARMA   IPCA LABS
EQUITY SHARE DATA
    VISTA PHARMA
Mar-20
IPCA LABS
Mar-21
VISTA PHARMA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs212,456 0.8%   
Low Rs51,371 0.3%   
Sales per share (Unadj.) Rs7.5423.3 1.8%  
Earnings per share (Unadj.) Rs-1.290.6 -1.3%  
Cash flow per share (Unadj.) Rs-0.8107.1 -0.7%  
Dividends per share (Unadj.) Rs08.00 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs9.8370.6 2.6%  
Shares outstanding (eoy) m30.37126.85 23.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.74.5 37.2%   
Avg P/E ratio x-10.421.1 -49.3%  
P/CF ratio (eoy) x-16.417.9 -91.9%  
Price / Book Value ratio x1.35.2 25.0%  
Dividend payout %08.8 0.0%   
Avg Mkt Cap Rs m383242,728 0.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1410,136 0.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m22853,699 0.4%  
Other income Rs m371,292 2.9%   
Total revenues Rs m26554,991 0.5%   
Gross profit Rs m-4814,812 -0.3%  
Depreciation Rs m132,092 0.6%   
Interest Rs m15123 12.6%   
Profit before tax Rs m-3913,890 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-32,401 -0.1%   
Profit after tax Rs m-3711,488 -0.3%  
Gross profit margin %-21.127.6 -76.4%  
Effective tax rate %6.617.3 38.0%   
Net profit margin %-16.221.4 -75.5%  
BALANCE SHEET DATA
Current assets Rs m21234,370 0.6%   
Current liabilities Rs m15911,331 1.4%   
Net working cap to sales %23.142.9 53.9%  
Current ratio x1.33.0 43.9%  
Inventory Days Days249 3.7%  
Debtors Days Days1656 2,988.1%  
Net fixed assets Rs m29626,295 1.1%   
Share capital Rs m61254 23.9%   
"Free" reserves Rs m23646,763 0.5%   
Net worth Rs m29647,017 0.6%   
Long term debt Rs m55365 15.1%   
Total assets Rs m50760,664 0.8%  
Interest coverage x-1.6114.2 -1.4%   
Debt to equity ratio x0.20 2,390.6%  
Sales to assets ratio x0.40.9 50.7%   
Return on assets %-4.219.1 -22.0%  
Return on equity %-12.424.4 -50.8%  
Return on capital %-6.829.6 -23.0%  
Exports to sales %18.50-   
Imports to sales %00-   
Exports (fob) Rs m42NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4427,172 0.2%   
Fx outflow Rs m07,949 0.0%   
Net fx Rs m4419,223 0.2%   
CASH FLOW
From Operations Rs m810,901 0.1%  
From Investments Rs m-17-5,207 0.3%  
From Financial Activity Rs m3-3,058 -0.1%  
Net Cashflow Rs m-62,636 -0.2%  

Share Holding

Indian Promoters % 6.2 46.3 13.4%  
Foreign collaborators % 20.7 0.0 -  
Indian inst/Mut Fund % 0.1 43.9 0.1%  
FIIs % 0.0 18.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 73.1 53.7 136.2%  
Shareholders   10,700 95,239 11.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VISTA PHARMA With:   PIRAMAL ENTERPRISES  LACTOSE INDIA  PROCTER & GAMBLE HEALTH  GENNEX LAB.  KREBS BIOCHEMICALS  



Today's Market

Sensex Trades Marginally Higher, Dow Futures Trade Flat(12:30 pm)

Share markets in India are presently trading marginally higher. The BSE Sensex is trading up by 218 points, up 0.4%, at 61,039 levels.

Related Views on News

IPCA LABS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of IPCA LABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of IPCA LABS. Also includes updates on the valuation of IPCA LABS.

IPCA LABS Announces Quarterly Results (1QFY22); Net Profit Down 30.8% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, IPCA LABS has posted a net profit of Rs 3 bn (down 30.8% YoY). Sales on the other hand came in at Rs 16 bn (up 2.0% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

VISTA PHARMA SHARE PRICE


Oct 25, 2021 03:36 PM

TRACK VISTA PHARMA

  • Track your investment in VISTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

VISTA PHARMA - SAKAR HEALTHCARE COMPARISON

COMPARE VISTA PHARMA WITH

MARKET STATS